Cargando…
Antiproliferative and apoptotic effect of LY2090314, a GSK-3 inhibitor, in neuroblastoma in vitro
BACKGROUND: Neuroblastoma (NB) is a devastating disease. Despite recent advances in the treatment of NB, about 60% of high-risk NB will have relapse and therefore long-term event free survival is very minimal. We have reported that targeting glycogen synthase kinase-3 (GSK-3) may be a potential stra...
Autores principales: | Kunnimalaiyaan, Selvi, Schwartz, Victoriana K., Jackson, Iris Alao, Clark Gamblin, T., Kunnimalaiyaan, Muthusamy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5948712/ https://www.ncbi.nlm.nih.gov/pubmed/29751783 http://dx.doi.org/10.1186/s12885-018-4474-7 |
Ejemplares similares
-
Antiproliferative and apoptotic effects of xanthohumol in cholangiocarcinoma
por: Walden, Daniel, et al.
Publicado: (2017) -
Xanthohumol increases death receptor 5 expression and enhances apoptosis with the TNF-related apoptosis-inducing ligand in neuroblastoma cell lines
por: Engelsgjerd, Samuel, et al.
Publicado: (2019) -
Inhibition of the AKT pathway in cholangiocarcinoma by MK2206 reduces cellular viability via induction of apoptosis
por: Wilson, Jacob M, et al.
Publicado: (2015) -
Xanthohumol Inhibits Notch Signaling and Induces Apoptosis in Hepatocellular Carcinoma
por: Kunnimalaiyaan, Selvi, et al.
Publicado: (2015) -
Activating the Wnt/β-Catenin Pathway for the Treatment of Melanoma – Application of LY2090314, a Novel Selective Inhibitor of Glycogen Synthase Kinase-3
por: Atkinson, Jennifer M., et al.
Publicado: (2015)